Quality biology support
Concept discussion & design
Biology, modality & technology validation
Target validation, prioritization and discovery
Assay cascade & target engagement
Drug – disease translational validation
Molecular indication & population selection
Path to drug & tech development
Path to clinic
Discover all our
accelerator solutions
Therapeutic relevance assessment: critical scientific gap analysis & advice
PoC validation: biology, modality or technology
Program prioritization for drug & tech development
Assay development for drug development & translational research
Molecular indication selection & patient stratification
Discover all our
accelerator solutions
Therapeutic relevance assessment: critical scientific gap analysis & advice
PoC validation: biology, modality or technology
Program prioritization for drug & tech development
Assay development for drug development & translational research
Molecular indication selection & patient stratification
Discover all our
accelerator solutions
Therapeutic relevance assessment: critical scientific gap analysis & advice
PoC validation: biology, modality or technology
Program prioritization for drug & tech development
Assay development for drug development & translational research
Molecular indication selection & patient stratification
Discover all our
accelerator solutions
Therapeutic relevance assessment: critical scientific gap analysis & advice
PoC validation: biology, modality or technology
Program prioritization for drug & tech development
Assay development for drug development & translational research
Molecular indication selection & patient stratification
Therapeutic relevance assessment: critical scientific gap analysis & advice
Get in touch
We can handle a wide spectrum of projects, ranging from target validation over therapeutic modality support up to technology platform pilot validation. Importantly, we are set up to offer solutions maximally adapted to your project-specific challenges.
PoC validation:
biology, target,
modality or technology
Get in touch
Program prioritization for drug & tech development
Get in touch
Early on we support target prioritization for initiation of drug development, thereby defining further company focus. At a later stage, we drive drug development program (de)prioritization based on MoA differentiation and/or match with disease (subtype) MoA.
Discovery Studio provides cellular and molecular assay development focused on multiparametric measurement quality, sensitivity and, if needed, industrialization readiness.
Assay development for drug development & translational research
Get in touch
Molecular indication selection & patient stratification
Get in touch
With a mix of computational power and strong bioinformatics knowhow, we support molecular selection of clinical indication and patient stratification.
What we do
Our capabilities
Bioinformatics, omics & cellular wetlab, senior support, research plan design.
Our facilities
Accelerate your promising therapies to patients in need.